Showing 121-130 of 1059 results for "".
Challenge Case Report: Acute Onset of Expressive Aphasia, Visual Disturbances, and Severe Headache
https://practicalneurology.com/programs/practical-neurology/challenge-case-report-acute-onset-of-expressive-aphasia-visual-disturbances-and-severe-headache/33146/The differential diagnosis in the setting of leptomeningeal enhancement is broad, but when seen in association with an expansile intraparenchymal mass, there should be high suspicion for a neoplastic process.Expert Opinion: Neuropsychological Impairments In Females with Primary Sjögren's Syndrome: New Insights
https://practicalneurology.com/columns/practice-management/expert-opinion-neuropsychological-impairments-in-females-with-primary-sjgrens-syndrome-new-insights/30854/The pSS literature has reported varying degrees of central nervous system involvement in individuals with this condition and secondary cognitive deficits associated with the disease.CIDP in an Adolescent After Pfizer-BioNTech COVID-19 Vaccination
https://practicalneurology.com/diseases-diagnoses/neuromuscular/cidp-in-an-adolescent-after-pfizer-biontech-covid-19-vaccination/32057/A case of pediatric CIDP temporally related to the Pfizer-BioNTech COVID-19 vaccine; more information is needed to leverage the vaccine-related risk with the risk associated with primary COVID-19.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31209/Cognitive and Behavioral Impacts of Antiepileptic Drugs in Epilepsy TreatmentAntiepileptic drugs (AEDs) are fundamental in managing epilepsy, yet their use is frequently associated with cognitive and behavioral side effects. The precise mechanisms underpinning these changes are not fully elucidated,
Biomarker Testing Modalities for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/biomarker-testing-modalities-for-alzheimer-disease/35432/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their p- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31204/Summary of Recent Advances and Findings in NeurologyThe 2007 American Stroke Association’s International Stroke Conference in San Francisco highlighted critical barriers in stroke management and innovative therapeutic advancements. A significant finding revealed that approximately 50% of individuals
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31042/Antiepileptic drugs (AEDs) are increasingly associated with various metabolic bone disorders, including osteomalacia, osteoporosis, and an elevated risk of fractures. Early studies highlighted these risks in institutionalized patients, but recent research extends these findings to outpatient populat
PD GENEration and Barriers to Parkinson Diagnosis - Part 1
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pd-generation-and-barriers-to-parkinson-diagnosis-part-1/30095/Chantale Branson, MD, Associate Professor of Neurology at Morehouse School of Medicine, Atlanta, GA, is a researcher working on the pivotal PD GENEration study, which aims to improve treatment options through the identification of clinically relevant genes linked to Parkinson disease. In this episodUpdate on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/31283/Stewart J. Tepper, MD, Vice President of the New England Institute for Neurology and Headache, Peter McAllister, MD, FAAN, Chief Medical Officer of the New England Institute for Neurology and Headache, and Teshamae Monteith, MD, Associate Professor and Chief of the Headache Division of the DepartmenVagus Nerve Stimulation: Effects Beyond the Nervous System
https://practicalneurology.com/programs/practical-neurology/vagus-nerve-stimulation-effects-beyond-the-nervous-system/30101/Stavros Zanos, MD, PhD, Associate Professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, uses neurostimulation as a means to study the nervous system and to treat diseases in which the nervous system is affected or implicated. In this episode, Dr. Zanos gives an o